U.S. markets open in 2 hours 55 minutes
  • S&P Futures

    4,076.50
    -4.75 (-0.12%)
     
  • Dow Futures

    34,530.00
    -69.00 (-0.20%)
     
  • Nasdaq Futures

    12,005.25
    -37.00 (-0.31%)
     
  • Russell 2000 Futures

    1,890.70
    +3.20 (+0.17%)
     
  • Crude Oil

    81.35
    +0.80 (+0.99%)
     
  • Gold

    1,792.90
    +33.00 (+1.88%)
     
  • Silver

    22.31
    +0.52 (+2.41%)
     
  • EUR/USD

    1.0443
    +0.0035 (+0.33%)
     
  • 10-Yr Bond

    3.7030
    0.0000 (0.00%)
     
  • Vix

    20.91
    -0.98 (-4.48%)
     
  • GBP/USD

    1.2160
    +0.0098 (+0.82%)
     
  • USD/JPY

    136.1750
    -1.9050 (-1.38%)
     
  • BTC-USD

    17,077.72
    +181.41 (+1.07%)
     
  • CMC Crypto 200

    404.54
    +3.85 (+0.96%)
     
  • FTSE 100

    7,579.01
    +5.96 (+0.08%)
     
  • Nikkei 225

    28,226.08
    +257.09 (+0.92%)
     

Prediction: This Growth Stock Could Double in 2023

Prediction: This Growth Stock Could Double in 2023

Biotech company Axsome Therapeutics (NASDAQ: AXSM) has had a strong -- although somewhat volatile -- year on the stock market. Let's consider why Axsome Therapeutics' stock could crush the market again next year. Axsome Therapeutics earned approval for Auvelity in August.